The marketplace connecting CE Professionals, Event Hosts, Business & Industry, and Speakers.

For Professionals

Browse Events
CE Professionals
Speakers & Authors

For Organizations

Exhibitors & Sponsors
Event Hosts

Company

About
Log In
Create Account
FAQ
Terms of Use
Privacy Policy
Sub-processors
Contact Us

The marketplace connecting CE Professionals, Event Hosts, Business & Industry, and Speakers.

For Professionals

Browse Events
CE Professionals
Speakers & Authors

For Organizations

Exhibitors & Sponsors
Event Hosts

Company

About
Log In
Create Account
FAQ
Terms of Use
Privacy Policy
Sub-processors
Contact Us

Terms Privacy

Newer Veterinary Oncology Drugs: Tanovea, Laverdia, Stelfonta and More | networkED.global

On Demand

Newer Veterinary Oncology Drugs: Tanovea, Laverdia, Stelfonta and More

Hosted by VetFolio

Dates TBD Online / Virtual

Veterinary Medicine

About This Event

This self-paced course reviews recent advancements in veterinary cancer therapy and diagnostics. Dr. Douglas H. Thamm covers new treatment options including Tigilanol tiglate for mast cell tumors, immune checkpoint inhibitors, Verdinexor for lymphoma, and Rabacfosadine for canine lymphoma, enhancing cancer treatment outcomes for dogs.

Registration & Fees

Who This Event Is For

Industries

Veterinary Medicine

Visit Event Website

You'll be redirected to the organizer's registration site

Key Dates

Event Start DateDates TBD

Attendee Registration Opens*

Early Bird Registration Deadline*

*These dates are not yet available from the host.